Welcome to the What's New Section of SpineTechNews.com, where you can learn, research, and participate in discussions about the latest developments in Spine Surgery.
The study outcomes will evaluate if injections of rhGDF-5 into the lower spine can relieve pain and slow or even reverse early stage degenerative disc disease.
Read More and Comment | Comments OffAn FDA advisory panel voted 6-1 that Stryker’s PMA for its OP-1 Putty for uninstrumented posterolateral fusion for the treatment of lumbar spondylolisthesis was not approvable. Stryker was seeking this approval based on 24 months of clinical outcome data and 36 month CT scan and reoperation rates
Read More and Comment | Comments OffThe ROI-A ALIF is a stand-alone spinal implant system with zero profile, self-locking plates designed for initial and long-term stability. The surgical technique is a direct anterior approach, with the curved plates inserted along the sagittal plane thus requiring no additional exposure to the vertebral bodies.
Read More and Comment | Comments OffMesoblast will use the funds to expand the company’s clinical trial programs focusing on the company’s stem cell based bone and cartilage regenerative products for spinal vertebral disc disease.
Read More and Comment | Comments OffGlobus Medical, Inc., the largest privately held spinal implant manufacturer in the world, announced the launch of MicroFuse ST Granules, a unique resorbable polymer bone void filler optimized for both strength and porosity.
Read More and Comment | Comments OffGerman medical device manufacturer Ziehm Imaging launched the new, compact Ziehm Solo(R) C-arm. This agile and versatile C-arm delivers excellent image quality while requiring minimal OR space.
Read More and Comment | Comments OffAOI believes that it has pioneered a better way to treat Vertebral Compression Fractures. The company’s lead product, Ascendx, is comprised of two main instruments: a cutting device and an expandable fracture reduction device.
Read More and Comment | Comments OffPatients suffering from lumbar spinal stenosis could benefit from a new surgical implant called the X-STOP.
Read More and Comment | Comments OffThe allowed claims within this patent application cover compositions of platelet derived growth factor (PDGF) combined with matrix materials having defined characteristics, which cover the Company’s novel recombinant protein-device combination product candidates.
Read More and Comment | Comments OffGlobus’ XPand devices, available in both titanium and PEEK, has been used in more than 3,300 cases for trauma or tumor surgeries.
Read More and Comment | Comments Off